Company Filing History:
Years Active: 2022
Title: The Innovations of Xi Zong
Introduction
Xi Zong is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modulators for indoleamine 2,3-dioxygenase. His work focuses on creating compounds that can be used in the treatment of various diseases, including cancers and neurodegenerative disorders.
Latest Patents
Xi Zong holds a patent for a modulator of indoleamine 2,3-dioxygenase, which includes a preparation method and its uses. The patent details compounds of Formula I and Formula II, along with their isomers, pharmaceutically acceptable salts, and solvates. These compounds are aimed at treating a range of conditions such as mental disorders, depression, anxiety disorders, Alzheimer's disease, and autoimmune diseases.
Career Highlights
Throughout his career, Xi Zong has worked with several pharmaceutical companies, including Nanjing Carephar Shenghui Pharmaceutical Co., Ltd. and Jiangsu Carephar Pharmaceutical Co., Ltd. His expertise in drug development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Xi Zong has collaborated with notable colleagues, including Yinlin Qin and Mei Su, who have contributed to his research and development efforts. Their teamwork has been instrumental in advancing the projects they have undertaken together.
Conclusion
Xi Zong's innovative work in the pharmaceutical field demonstrates his commitment to improving healthcare through the development of new treatments. His contributions are paving the way for advancements in the treatment of serious medical conditions.